{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,5,13]],"date-time":"2025-05-13T17:36:56Z","timestamp":1747157816092,"version":"3.40.5"},"reference-count":29,"publisher":"Elsevier BV","issue":"7","license":[{"start":{"date-parts":[[2024,11,1]],"date-time":"2024-11-01T00:00:00Z","timestamp":1730419200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2024,11,1]],"date-time":"2024-11-01T00:00:00Z","timestamp":1730419200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2024,11,1]],"date-time":"2024-11-01T00:00:00Z","timestamp":1730419200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2024,11,1]],"date-time":"2024-11-01T00:00:00Z","timestamp":1730419200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2024,11,1]],"date-time":"2024-11-01T00:00:00Z","timestamp":1730419200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2024,11,1]],"date-time":"2024-11-01T00:00:00Z","timestamp":1730419200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2024,11,1]],"date-time":"2024-11-01T00:00:00Z","timestamp":1730419200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["clinicalkey.fr","clinicalkey.jp","clinicalkey.es","clinicalkey.com.au","clinicalkey.com","clinical-lung-cancer.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Clinical Lung Cancer"],"published-print":{"date-parts":[[2024,11]]},"DOI":"10.1016\/j.cllc.2024.08.008","type":"journal-article","created":{"date-parts":[[2024,8,23]],"date-time":"2024-08-23T01:41:51Z","timestamp":1724377311000},"page":"653-659.e1","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"title":["Association of Serum Biomarkers With Neurocognitive Decline After PCI in Small Cell Lung Cancer: An Exploratory Study of the Phase III NCT01780675 Trial"],"prefix":"10.1016","volume":"25","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-5976-6084","authenticated-orcid":false,"given":"Haiyan","family":"Zeng","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Lizza E.L.","family":"Hendriks","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jos\u00e9","family":"Belderbos","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Lloyd","family":"Brandts","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Inge","family":"Compter","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ludwig","family":"Dubois","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Matthew G.","family":"Holt","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ruud","family":"Houben","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sanne","family":"Schagen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Xin","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Teresa","family":"Prezzemolo","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Dirk","family":"De Ruysscher","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.cllc.2024.08.008_bib0001","doi-asserted-by":"crossref","first-page":"840","DOI":"10.1016\/j.jtho.2020.12.024","article-title":"Phase 3 randomized trial of prophylactic cranial irradiation with or without hippocampus avoidance in SCLC (NCT01780675)","volume":"16","author":"Belderbos","year":"2021","journal-title":"J Thorac Oncol"},{"key":"10.1016\/j.cllc.2024.08.008_bib0002","doi-asserted-by":"crossref","first-page":"3118","DOI":"10.1200\/JCO.21.00639","article-title":"Randomized phase III trial of prophylactic cranial irradiation with or without hippocampal avoidance for small-cell lung cancer (PREMER): a GICOR-GOECP-SEOR study","volume":"39","author":"Rodr\u00edguez de Dios","year":"2021","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.cllc.2024.08.008_bib0003","doi-asserted-by":"crossref","first-page":"3810","DOI":"10.1200\/JCO.2014.57.2909","article-title":"Preservation of memory with conformal avoidance of the hippocampal neural stem-cell compartment during whole-brain radiotherapy for brain metastases (RTOG 0933): a phase II multi-institutional trial","volume":"32","author":"Gondi","year":"2014","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.cllc.2024.08.008_bib0004","doi-asserted-by":"crossref","first-page":"1019","DOI":"10.1200\/JCO.19.02767","article-title":"Hippocampal avoidance during whole-brain radiotherapy plus memantine for patients with brain metastases: phase III trial NRG oncology CC001","volume":"38","author":"Brown","year":"2020","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.cllc.2024.08.008_bib0005","doi-asserted-by":"crossref","first-page":"1429","DOI":"10.1093\/neuonc\/not114","article-title":"Memantine for the prevention of cognitive dysfunction in patients receiving whole-brain radiotherapy: a randomized, double-blind, placebo-controlled trial","volume":"15","author":"Brown","year":"2013","journal-title":"Neuro Oncol"},{"key":"10.1016\/j.cllc.2024.08.008_bib0006","doi-asserted-by":"crossref","first-page":"74","DOI":"10.1016\/j.cct.2015.12.013","article-title":"The impact of RTOG 0614 and RTOG 0933 trials in routine clinical practice: the US survey of utilization of memantine and IMRT planning for hippocampus sparing in patients receiving whole brain radiotherapy for brain metastases","volume":"47","author":"Slade","year":"2016","journal-title":"Contemp Clin Trials"},{"key":"10.1016\/j.cllc.2024.08.008_bib0007","doi-asserted-by":"crossref","DOI":"10.1016\/j.ctrv.2020.102025","article-title":"Risk factors for neurocognitive decline in lung cancer patients treated with prophylactic cranial irradiation: a systematic review","volume":"88","author":"Zeng","year":"2020","journal-title":"Cancer Treat Rev"},{"key":"10.1016\/j.cllc.2024.08.008_bib0008","doi-asserted-by":"crossref","first-page":"1123","DOI":"10.1093\/neuonc\/noac262","article-title":"Association of circulating markers with cognitive decline after radiation therapy for brain metastasis","volume":"25","author":"Huntoon","year":"2023","journal-title":"Neuro Oncol"},{"key":"10.1016\/j.cllc.2024.08.008_bib0009","doi-asserted-by":"crossref","first-page":"846","DOI":"10.1016\/j.ijrobp.2023.12.004","article-title":"Impact of apolipoprotein E genotype on neurocognitive function in patients with brain metastases: an analysis of NRG oncology's RTOG 0614","volume":"119","author":"Wefel","year":"2024","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.cllc.2024.08.008_bib0010","doi-asserted-by":"crossref","first-page":"109","DOI":"10.1186\/s12905-020-00971-1","article-title":"Preliminary study on the effects of treatment for breast cancer: immunological markers as they relate to quality of life and neuropsychological performance","volume":"20","author":"Boivin","year":"2020","journal-title":"BMC Womens Health"},{"key":"10.1016\/j.cllc.2024.08.008_bib0011","doi-asserted-by":"crossref","first-page":"308","DOI":"10.1016\/j.bbi.2019.04.008","article-title":"Worsening cognitive performance is associated with increases in systemic inflammation following hematopoietic cell transplantation","volume":"80","author":"Hoogland","year":"2019","journal-title":"Brain Behav Immun"},{"issue":"39","key":"10.1016\/j.cllc.2024.08.008_bib0012","first-page":"e153","article-title":"Serum NFL discriminates Parkinson disease from essential tremor and reflect motor and cognition severity","volume":"22","author":"Huang","year":"2022","journal-title":"BMC Neurol"},{"key":"10.1016\/j.cllc.2024.08.008_bib0013","article-title":"Persistence of inflammatory and vascular mediators 5 months after hospitalization with COVID-19 infection","volume":"10","author":"Melhorn","year":"2023","journal-title":"Front Med (Lausanne)"},{"key":"10.1016\/j.cllc.2024.08.008_bib0014","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2022.964179","article-title":"Inflammatory mediators profile in patients hospitalized with COVID-19: a comparative study","volume":"13","author":"Tufa","year":"2022","journal-title":"Front Immunol"},{"key":"10.1016\/j.cllc.2024.08.008_bib0015","doi-asserted-by":"crossref","DOI":"10.3389\/fpsyt.2022.834539","article-title":"Network association of biochemical and inflammatory abnormalities with psychiatric symptoms in first-episode schizophrenia patients","volume":"13","author":"Yan","year":"2022","journal-title":"Front Psychiatry"},{"key":"10.1016\/j.cllc.2024.08.008_bib0016","doi-asserted-by":"crossref","first-page":"2971","DOI":"10.2147\/PRBM.S384267","article-title":"Serum CC chemokines as potential biomarkers for the diagnosis of major depressive disorder","volume":"15","author":"Gao","year":"2022","journal-title":"Psychol Res Behav Manag"},{"key":"10.1016\/j.cllc.2024.08.008_bib0017","doi-asserted-by":"crossref","DOI":"10.1016\/j.celrep.2021.109522","article-title":"The angiopoietin-Tie2 pathway regulates Purkinje cell dendritic morphogenesis in a cell-autonomous manner","volume":"36","author":"Luck","year":"2021","journal-title":"Cell Rep"},{"key":"10.1016\/j.cllc.2024.08.008_bib0018","doi-asserted-by":"crossref","first-page":"885","DOI":"10.1007\/s13365-021-01001-y","article-title":"The relationship between vascular endothelial growth factor (VEGF) and amnestic mild cognitive impairment among older adults living with HIV","volume":"27","author":"Serrano","year":"2021","journal-title":"J Neurovirol"},{"key":"10.1016\/j.cllc.2024.08.008_bib0019","doi-asserted-by":"crossref","first-page":"1003","DOI":"10.3233\/JAD-160477","article-title":"Severity-related increase and cognitive correlates of serum VEGF levels in Alzheimer's disease ApoE4 carriers","volume":"63","author":"Alvarez","year":"2018","journal-title":"J Alzheimers Dis"},{"key":"10.1016\/j.cllc.2024.08.008_bib0020","doi-asserted-by":"crossref","first-page":"e126","DOI":"10.1192\/bjo.2021.966","article-title":"Inflammatory biomarkers and cognitive functioning in individuals with euthymic bipolar disorder: exploratory study","volume":"7","author":"Strawbridge","year":"2021","journal-title":"BJPsych Open"},{"key":"10.1016\/j.cllc.2024.08.008_bib0021","doi-asserted-by":"crossref","first-page":"600","DOI":"10.1111\/imcb.12644","article-title":"CCL17\/TARC in autoimmunity and inflammation-not just a T-cell chemokine","volume":"101","author":"Lupancu","year":"2023","journal-title":"Immunol Cell Biol"},{"key":"10.1016\/j.cllc.2024.08.008_bib0022","doi-asserted-by":"crossref","first-page":"e193","DOI":"10.1212\/NXI.0000000000000193","article-title":"Converging mediators from immune and trophic pathways to identify Parkinson disease dementia","volume":"3","author":"Lue","year":"2016","journal-title":"Neurol Neuroimmunol Neuroinflamm"},{"key":"10.1016\/j.cllc.2024.08.008_bib0023","doi-asserted-by":"crossref","first-page":"166","DOI":"10.3325\/cmj.2019.60.166","article-title":"Interleukin 1 level, cognitive performance, and severity of depressive symptoms in patients treated with systemic anticancer therapy: a prospective study","volume":"60","author":"Jasionowska","year":"2019","journal-title":"Croat Med J"},{"key":"10.1016\/j.cllc.2024.08.008_bib0024","doi-asserted-by":"crossref","first-page":"972","DOI":"10.2174\/1567205017666201130092427","article-title":"The association between TNF-alpha, IL-1 alpha and IL-10 with Alzheimer's disease","volume":"17","author":"Culjak","year":"2020","journal-title":"Curr Alzheimer Res"},{"key":"10.1016\/j.cllc.2024.08.008_bib0025","doi-asserted-by":"crossref","first-page":"342","DOI":"10.1186\/s12974-018-1376-1","article-title":"Circulating levels of IL-1 family cytokines and receptors in Alzheimer's disease: new markers of disease progression?","volume":"15","author":"Italiani","year":"2018","journal-title":"J Neuroinflammation"},{"key":"10.1016\/j.cllc.2024.08.008_bib0026","doi-asserted-by":"crossref","first-page":"2945","DOI":"10.1002\/mds.28779","article-title":"Neurofilament light chain as a biomarker for cognitive decline in parkinson disease","volume":"36","author":"Aamodt","year":"2021","journal-title":"Mov Disord"},{"key":"10.1016\/j.cllc.2024.08.008_bib0027","doi-asserted-by":"crossref","first-page":"695","DOI":"10.1007\/s13365-018-0664-y","article-title":"Neurofilament light chain in blood is negatively associated with neuropsychological performance in HIV-infected adults and declines with initiation of antiretroviral therapy","volume":"24","author":"Anderson","year":"2018","journal-title":"J Neurovirol"},{"key":"10.1016\/j.cllc.2024.08.008_bib0028","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1016\/S0006-8993(03)03219-0","article-title":"Elevated neurofilament levels in neurological diseases","volume":"987","author":"Norgren","year":"2003","journal-title":"Brain Res"},{"key":"10.1016\/j.cllc.2024.08.008_bib0029","doi-asserted-by":"crossref","first-page":"1832","DOI":"10.1002\/acn3.51676","article-title":"Age- and disease-specific reference values for neurofilament light presented in an online interactive support interface","volume":"9","author":"Vermunt","year":"2022","journal-title":"Ann Clin Transl Neurol"}],"container-title":["Clinical Lung Cancer"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1525730424001803?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1525730424001803?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2024,10,29]],"date-time":"2024-10-29T23:45:30Z","timestamp":1730245530000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1525730424001803"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,11]]},"references-count":29,"journal-issue":{"issue":"7","published-print":{"date-parts":[[2024,11]]}},"alternative-id":["S1525730424001803"],"URL":"https:\/\/doi.org\/10.1016\/j.cllc.2024.08.008","relation":{},"ISSN":["1525-7304"],"issn-type":[{"type":"print","value":"1525-7304"}],"subject":[],"published":{"date-parts":[[2024,11]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Association of Serum Biomarkers With Neurocognitive Decline After PCI in Small Cell Lung Cancer: An Exploratory Study of the Phase III NCT01780675 Trial","name":"articletitle","label":"Article Title"},{"value":"Clinical Lung Cancer","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.cllc.2024.08.008","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2024 Elsevier Inc. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}]}}